Physician profile
Patrick M Crawford
NPI 1619959541
$1,133.08
in general payments reported to CMS, 2019-2025
12 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $253 · 2021: $67.99 · 2022: $115 · 2023: $48.49 · 2024: $110 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $251.27 | 2019-2023 | Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3 |
| Carl Zeiss Meditec, INC. | $241.19 | 2020 | |
| Alcon Vision LLC | $157.53 | 2019-2024 | Wavelight Refractive Suite, Clareon |
| Tarsus Pharmaceuticals, INC. | $121.55 | 2025 | Xdemvy |
| Allergan, INC. | $77.78 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $54.30 | 2022 | |
| Dompe US, INC. | $50.29 | 2019-2025 | Oxervate |
| Horizon Therapeutics Plc | $48.35 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $43.62 | 2020-2021 | |
| Optos, INC. | $35.95 | 2019 | |
| Abbvie INC. | $32.79 | 2024 | |
| Oyster Point Pharma, INC. | $18.46 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Crawford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.